Further, our data highlight that beyond antioxidant effects, relevant pulmonary genes and pathways implicated in the development of BPD are differentially modulated by the intersection of perinatal Se status, Nrf2 signaling and hyperoxia in the neonatal lung. The gene discussed is NFE2L2; the disease is bronchopulmonary dysplasia.